Identification of a novel Providencia species showing multi-drug-resistant in three patients with hospital-acquired infection
Weiwei Yang,Jing Chen,Fengzhen Yang,Ping Ji,Siquan Shen,Dandan Yin,Fupin Hu
DOI: https://doi.org/10.1016/j.ijantimicag.2024.107211
IF: 15.441
2024-05-26
International Journal of Antimicrobial Agents
Abstract:Providencia species are important opportunistic pathogens for humans and are associated with several infectious diseases. In this study, we found three clinical strains belonging to a novel Providencia species, namely Providencia huashanensis , including strains CRE-3FA-0001 T , CRE-138-0026, and CRE-138-0111. These strains were recovered from three patients, and all of them were associated with nosocomial infections, including surgical site, urinary tract, and intracranial infections. The three strains showed high-level resistance to many types of antimicrobials, including amikacin, aztreonam, ceftazidime, cefepime, ciprofloxacin, colistin, polymyxin B, imipenem, meropenem, ceftazidime-avibactam, imipenem-relebactam. Investigation of the resistance mechanism revealed that acquired resistance genes such as bla KPC , bla NDM , bla PER , bla OXA , aac, ant, qnrD, etc., played an important role in the multidrug-resistant phenotype for the three strains. The phylogenetic trees were reconstructed based on the 16S rRNA gene sequences, multi-locus sequence analysis, and core SNPs. The genome sequence of the strains had a range of 83.5-85.8% average nucleotide identity (ANI) and 21-25.5% in silico DNA-DNA hybridization (isDDH) score with other Providencia type strains. The ANI&isDDH values and the phylogenetic tree indicated that the strains CRE-3FA-0001 T , CRE-138-0026, and CRE-138-0111 strains should be considered as a novel species of the genus Providencia , for which the name P. huashanensis sp. nov. is proposed. The type strain is CRE-3FA-0001 T =CCTCC AB 2023186 T =KCTC 8373 T .
pharmacology & pharmacy,infectious diseases,microbiology